Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers-Reference-Cited by-同舟云学术

Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers

Published:2022-11 Issue: Volume:Volume 16 Page:3081-3094
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Akazawa Manabu^ORCID,Shima Daisuke^ORCID,Sato Takahiro^ORCID,Shoji Emi,LoPresti Michael^ORCID,Nishi Ryosuke^ORCID

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference47 articles.

1. Merck Sharp & Dohme Corp. Merck Manual Professional Version. New Jersey: Merck Sharp & Dohme Corp; 2021.

2. Ministry of Health, Labor and Welfare. Research on the practical infrastructure for the promotion of measures against chronic specific diseases in children. Policy Research Project on Intractable Diseases (Policy Research Project on Intractable Diseases). Study Report. FY2008-2010. Ministry of Health, Labor and Welfare. Available from: https://www.shouman.jp/research/pdf/23_2830/2830_18.pdf. Accessed October 19, 2022.

3. Ministry of Health, Labor and Welfare. A guide to the diagnosis and treatment of interstitial pituitary dysfunction. FY2008 health and labor sciences research grants for intractable diseases policy research project research: research on pituitary gland dysfunction. Ministry of Health, Labor and Welfare; 2008.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Effective growth hormone replacement with once‐weekly somapacitan in Japanese children with growth hormone deficiency: Results from REAL4, a phase 3 clinical trial;Clinical Endocrinology;2024-02-18